IDL Diagnostics AB (publ) (STO:IDLDX)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Bacteriology	29.58M	35.64M	-	-	-
Oncology	23.46M	21.68M	-	-	-
Other Segments	76.00K	109.00K	-	-	-
Biotechnology	-	-	43.04M	36.99M	12.00M
Total	53.11M	57.44M	43.04M	36.99M	12.00M

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe	23.21M	20.17M	-	-	-
Asia	29.48M	36.80M	-	-	-
Americas	139.00K	368.00K	-	-	-
Mea	171.00K	64.00K	-	-	-
Africa	113.00K	31.00K	-	-	-
Sweden	-	-	43.04M	36.99M	12.00M
Total	53.11M	57.44M	43.04M	36.99M	12.00M

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error